LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Ultrasound – Drug-Free Treatment for Muscular Pain
Large Joints and Extremities

Ultrasound – Drug-Free Treatment for Muscular Pain

August 7, 2014 2 min read Premium comments

Advertisement

Ultrasound – Drug-Free Treatment for Muscular Pain
Ultrasound Device / Courtesy: ZetrOZ
Secondary

It undoubtedly all started when George K. Lewis, a director of the Analogic Corporation, Peabody, Massachusetts, took his middle school age son, George, Jr. to work with him. He set young Lewis up at a lab bench with other technicians, introduced him to electronics and soon had him wiring and soldering together his inventions. Lewis, Senior, worked with ultrasound and Junior earned his Ph.D. in biomedical ultrasonics. His thesis was titled “Ultrasound Assisted Drug Delivery to the Brain.”

When he was 25 years old Lewis, Jr. founded ZetrOZ, a medical manufacturer of therapeutic ultrasound devices. Lewis told OTW that their device, called “sam”, is the smallest, portable, therapeutic ultrasound system on the market and in the world—a noninvasive, drug-free alternative for treating chronic pain. “sam” is the first long-duration, therapeutic ultrasound device to receive 501(k) clearance from the FDA. In doing so, Lewis says, the FDA defined a whole new branch of medicine—one dealing with sustained acoustic medicine.

“sam” is available in the United States only with a prescription from a licensed healthcare provider. In Canada and in Europe, where it is CE-marked, it can be purchased over-the-counter.

The fledgling company’s first product was not “sam”, but an ultrasonic treatment for race horses called Ultroz. In 2011 Ultroz went with the Olympic Equestrian Team to London where trainers used it to treat overuse injuries and strained muscles in the horses.

The device, “sam”, operates on the same principal. It uses high frequency ultrasound energy waves to produce deep mechanical stimulation within the body. It “increases circulation, reduces inflammation, is clinically proven to be an effective deep therapeutic treatment for select medical concerns and, when used daily, provides added therapeutic benefit for chronic pain sufferers, ” Lewis said. The National Institute of Health has given a major grant to ZetrOZ to support clinical trials of “sam” for knee osteoarthritis pain.

“The use of therapeutic ultrasound to treat a variety of conditions, including musculoskeletal pain, offers great promise for patients, ” said Thomas M. Best, M.D., professor and Pomerene Chair, Division of Sports Medicine, Ohio State University. “In particular, this low intensity, iPod-sized, wearable, battery powered device and its early success in a series of pilot studies, represent a breakthrough in our abilities to treat patients in a user friendly convenient manner.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy